2 news items
InterCure Reports Strong FY2023: Performance Paves the Way for Global Expansion
INCR
2 May 24
offerings, and our focus on adding value for our customers and investors remain pivotal to our ongoing success and growth," Rabinovitch concluded
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million
INCR
1 May 24
, dedication to expanding internationally, enhancing our product offerings, and our focus on adding value for our customers and investors remain pivotal
- Prev
- 1
- Next